However, immuno-reactivities neither in neurons (NeuN) nor in astrocytes (GFAP) were detected, suggesting that microglial or endothelial cell-induced AIM2 production mediated post-stroke cognitive impairment pathogenesis. The gene discussed is RBFOX3; the disease is stroke disorder.